Sessions that Ezintsha Prof Venter and Angela Tembo will be part of https://www.iasociety.org
- Lesson learned from the “DTG story”
- Leveraging innovations to end the HIV pandemic
- What if one-size INSTI doesn’t fit all?
- Person-centred services: Design and implementation of effective HIV prevention and care
- Unlocking access: The journey to affordable HIV PrEP in LMICs
- Re-shaping landscapes to support embedded, programme science to improve population-level impact for HIV and STBBI programming: A call for transformative action
Search
Recent News
- DOR/ISL 100 mg/0.25 mg QD in HIV-1 antiretroviral treatment naive
- Follow-up of Participants Who Received DOR/ISL (100 mg/0.75 mg)
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
- A Phase 3 trial to assess efficacy and safety of M72/AS01E-4 Mycobacterium tuberculosis (Mtb) vaccine when administered to adolescents and adults
- This is an interventional, randomised, double-blind, placebo-controlled, two-armed, parallel-group, multicentre, multinational clinical study